Department of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel.
Nat Rev Cancer. 2018 Jun;18(6):359-376. doi: 10.1038/s41568-018-0006-7.
The concept that progression of cancer is regulated by interactions of cancer cells with their microenvironment was postulated by Stephen Paget over a century ago. Contemporary tumour microenvironment (TME) research focuses on the identification of tumour-interacting microenvironmental constituents, such as resident or infiltrating non-tumour cells, soluble factors and extracellular matrix components, and the large variety of mechanisms by which these constituents regulate and shape the malignant phenotype of tumour cells. In this Timeline article, we review the developmental phases of the TME paradigm since its initial description. While illuminating controversies, we discuss the importance of interactions between various microenvironmental components and tumour cells and provide an overview and assessment of therapeutic opportunities and modalities by which the TME can be targeted.
一个多世纪以前,Stephen Paget 提出了癌症的进展是由癌细胞与其微环境相互作用所调控的观点。当前的肿瘤微环境(TME)研究侧重于鉴定肿瘤相互作用的微环境成分,例如驻留或浸润的非肿瘤细胞、可溶性因子和细胞外基质成分,以及这些成分调节和塑造肿瘤细胞恶性表型的多种机制。在这篇时间线文章中,我们回顾了 TME 范式自最初描述以来的发展阶段。在阐明争议的同时,我们讨论了各种微环境成分与肿瘤细胞相互作用的重要性,并提供了 TME 靶向治疗机会和方式的概述和评估。